Chase Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Chase Investment Counsel's BMY Position: Q2 2026 in Review
Chase Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,838 shares worth $221K. The position accounts for 0.05% of the portfolio, ranked #129.
Chase Investment Counsel first reported a position in BMY in Q4 2019 and has held it in 8 quarters since. The position peaked at $4.89M in Q1 2020. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Chase Investment Counsel held 3,838 shares of Bristol-Myers Squibb worth $221K as of Q2 2026.
- Chase Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Chase Investment Counsel's portfolio in Q2 2026, its #129 holding.
- Chase Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 8 quarters since.
- Chase Investment Counsel's Bristol-Myers Squibb position peaked at $4.89M in Q1 2020.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.